You are here

  • Home
  • Archive
  • Volume 77, Issue Suppl 2
  • FRI0122 Drug survival of adalimumab in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis over 10 years in real-world setting of czech registry attra

Article metrics

Article menu
Download PDFPDF
FRIDAY, 15 JUNE 2018
Rheumatoid arthritis – biological DMARDs
FRI0122 Drug survival of adalimumab in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis over 10 years in real-world setting of czech registry attra

 

Online download statistics by month:

Online download statistics by month: June 2018 to April 2022

AbstractFullPdf
Jun 20181803
Jul 20181803
Aug 20184004
Sep 20181800
Oct 20185003
Nov 20182201
Dec 20182804
Jan 20192301
Feb 20192001
Mar 20192802
Apr 20192600
May 20192101
Jun 20191700
Jul 20191900
Aug 20191700
Sep 20192402
Oct 20191201
Nov 2019701
Dec 20193402
Jan 20202201
Feb 2020600
Mar 20202700
Apr 2020600
May 20202000
Jun 20201701
Jul 20202000
Aug 2020700
Sep 20201800
Oct 20206000
Nov 20202801
Dec 20201201
Jan 2021400
Feb 20211001
Mar 2021400
Apr 2021200
May 2021400
Jun 2021102
Jul 2021200
Aug 2021001
Sep 2021101
Oct 20211501
Nov 2021600
Dec 20212601
Jan 20221600
Feb 2022802
Mar 20222200
Apr 2022600
Total812042